II期霍奇金淋巴瘤患者博来霉素过量用药错误一例报告
本文报告一例25岁II期霍奇金淋巴瘤患者在ABVD方案第三周期化疗时,误接受通常剂量10倍的博来霉素(150 USP单位)。发现错误后立即给予静脉补液、呋塞米促进药物清除,并使用甲泼尼龙和乙酰半胱氨酸预防肺损伤。患者出现轻度恶心和轻度皮疹,治疗后逐渐好转;PET-CT评估后接受四个周期AVD化疗,治疗期间及1年随访未见其他明显异常。
要点
- 博来霉素剂量命名不一致普遍存在,增加用药错误风险
- 本例误用剂量为常规ABVD方案中博来霉素剂量的10倍(150 USP单位)
- 过量后给予补液、利尿、糖皮质激素和乙酰半胱氨酸,患者仅出现轻度恶心和皮疹
核心结论
- 博来霉素过量用药错误可导致轻度不良反应,经积极处理后可恢复,后续化疗需谨慎选择。
- 此类病例的毒性表现、临床管理和后续化疗选择值得重视,管理措施可供其他医院参考。
研究设计与样本
- 个案报告:一例25岁II期霍奇金淋巴瘤患者在ABVD方案第三周期化疗时发生博来霉素过量用药错误。
主要发现
- 患者误接受150 USP单位的博来霉素,为ABVD方案中常规剂量的10倍。
- 发现错误后立即给予静脉补液和呋塞米促进药物清除,并给予甲泼尼龙和乙酰半胱氨酸预防肺损伤。
- 患者出现轻度恶心和轻度皮疹,治疗后逐渐好转。
- PET-CT评估后患者接受四个周期AVD化疗,治疗期间及1年随访未见其他明显异常。
临床怎么用
- 发现博来霉素过量后应立即采取措施促进药物清除,并预防肺损伤。
- 过量事件后需重新评估病情并谨慎选择后续化疗方案。
局限性
- 本文为单例个案报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bleomycin is an antibiotic with cytotoxic properties that is commonly used in combination regimens for the treatment of Hodgkin lymphoma. The inconsistency in the dosage nomenclature of bleomycin appears universally, which increases the risk of medication errors. However, to the best of our knowledge, no such cases have been reported. Herein, we present a rare case report of a medication error caused by a bleomycin overdose. At the third cycle of chemotherapy, a 25-year-old patient with stage II Hodgkin lymphoma received a 10 times higher dose of bleomycin (150 USP) than that usually used as part of the doxorubicin, bleomycin, vindesine and dacarbazine protocol (ABVD). After the medication error was discovered, the patient was immediately treated with intravenous rehydration and furosemide to promote drug clearance. Additionally, methylprednisone and acetylcysteine were administered to prevent lung injury. However, the patient developed slight nausea and mild rash, which gradually improved after treatment. After evaluation with positron emission spectrometry-computed tomography (PET-CT), the patient received four cycles of AVD chemotherapy. No other obvious abnormalities were observed during the treatment and 1-year follow-up period. Hence, the toxicities, clinical management and selection of further chemotherapy after bleomycin overdose in such cases deserved serious attention. More importantly, management measures after this error may be used as a reference in other hospitals.
引用
- Jieting Z, Shuyi X, Xiaolin C, et al. Bleomycin overdose in a patient with stage II Hodgkin lymphoma: A case report of a medication error. Br J Clin Pharmacol. 2023. PMID: 37060160. doi:10.1111/bcp.15744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。